National Multiple Sclerosis Society
Based in DC
🤖
AI Overview
With $2.7M in lobbying spend across 39 quarterly filings, National Multiple Sclerosis Society is a significant lobbying presence. They deploy 14 individual lobbyists Their lobbying covers 10 issue areas. Active from 2018 to 2025.
$2.7M
Total Spend
8
Years Active
1
Firms Hired
14
Lobbyists Deployed
10
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $475K |
| 2019 | $446K |
| 2020 | $325K |
| 2021 | $200K |
| 2022 | $312K |
| 2023 | $305K |
| 2024 | $319K |
| 2025 | $295K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues, Civil Rights, Transportation, MED and 5 more
- •- Department of Defense Appropriations Act, 2018, support $6 million for the Multiple Sclerosis Research Program (MSRP).
- •- Department of Labor, Health and Human Services and Education and Related Agen
- •-Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with
- •H.R. 620, ADA Education and Reform Act, oppose passage.
- •None this quarter.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
DOGE vs. the Lobbying Machine
Government efficiency meets the lobbying industrial complex.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.